Name:
Osteogenesis Imperfecta
Description:
Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid (TOPaZ)
Stage:
Ongoing, closed to recruitment
Principal Investigator:
Prof Rachel Crowley
Sponsor:
University of Edinburgh
Network Partners
